123 related articles for article (PubMed ID: 28720310)
1. Epithelial membrane protein 2: Molecular interactions and clinical implications.
Chung LK; Bhatt NS; Lagman C; Pelargos PE; Qin Y; Gordon LK; Wadehra M; Yang I
J Clin Neurosci; 2017 Oct; 44():84-88. PubMed ID: 28720310
[TBL] [Abstract][Full Text] [Related]
2. Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastoma.
Qin Y; Fu M; Takahashi M; Iwanami A; Kuga D; Rao RG; Sudhakar D; Huang T; Kiyohara M; Torres K; Dillard C; Inagaki A; Kasahara N; Goodglick L; Braun J; Mischel PS; Gordon LK; Wadehra M
J Biol Chem; 2014 May; 289(20):13974-85. PubMed ID: 24644285
[TBL] [Abstract][Full Text] [Related]
3. Tissue microarray analysis for epithelial membrane protein-2 as a novel biomarker for gliomas.
Chung LK; Pelargos PE; Chan AM; Demos JV; Lagman C; Sheppard JP; Nguyen T; Chang YL; Hojat SA; Prins RM; Liau LM; Nghiemphu L; Lai A; Cloughesy TF; Yong WH; Gordon LK; Wadehra M; Yang I
Brain Tumor Pathol; 2018 Jan; 35(1):1-9. PubMed ID: 28887715
[TBL] [Abstract][Full Text] [Related]
4. Targeted Therapies for the Treatment of Glioblastoma in Adults.
Chuang DF; Lin X
Curr Oncol Rep; 2019 May; 21(7):61. PubMed ID: 31102038
[TBL] [Abstract][Full Text] [Related]
5. Epithelial membrane protein 2 modulates infectivity of Chlamydia muridarum (MoPn).
Shimazaki K; Wadehra M; Forbes A; Chan AM; Goodglick L; Kelly KA; Braun J; Gordon LK
Microbes Infect; 2007 Jul; 9(8):1003-10. PubMed ID: 17544801
[TBL] [Abstract][Full Text] [Related]
6. Epithelial membrane protein-2 regulates surface expression of alphavbeta3 integrin in the endometrium.
Wadehra M; Forbes A; Pushkarna N; Goodglick L; Gordon LK; Williams CJ; Braun J
Dev Biol; 2005 Nov; 287(2):336-45. PubMed ID: 16216233
[TBL] [Abstract][Full Text] [Related]
7. Epithelial membrane protein 2 (EMP2): A systematic review of its implications in pathogenesis.
Mozaffari K; Mekonnen M; Harary M; Lum M; Aguirre B; Chandla A; Wadehra M; Yang I
Acta Histochem; 2023 Jan; 125(1):151976. PubMed ID: 36455339
[TBL] [Abstract][Full Text] [Related]
8. [Targeted therapy in glioblastoma: update and perspectives].
Idbaih A; Duran-Peña A; Alentorn A
Bull Acad Natl Med; 2015 Nov; 199(8-9):1323-1329. PubMed ID: 29874421
[TBL] [Abstract][Full Text] [Related]
9. Epithelial membrane protein 2 regulates sphingosylphosphorylcholine-induced keratin 8 phosphorylation and reorganization: Changes of PP2A expression by interaction with alpha4 and caveolin-1 in lung cancer cells.
Lee EJ; Park MK; Kim HJ; Kim EJ; Kang GJ; Byun HJ; Lee CH
Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1157-69. PubMed ID: 26876307
[TBL] [Abstract][Full Text] [Related]
10. The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy.
Wang G; Wang J; Zhao H; Wang J; Tony To SS
Arch Biochem Biophys; 2015 Aug; 580():84-92. PubMed ID: 26151775
[TBL] [Abstract][Full Text] [Related]
11. The DNA methylome of glioblastoma multiforme.
Martinez R; Esteller M
Neurobiol Dis; 2010 Jul; 39(1):40-6. PubMed ID: 20064612
[TBL] [Abstract][Full Text] [Related]
12. A Rationale for Targeting Extracellular Regulated Kinases ERK1 and ERK2 in Glioblastoma.
Hannen R; Hauswald M; Bartsch JW
J Neuropathol Exp Neurol; 2017 Oct; 76(10):838-847. PubMed ID: 28922853
[TBL] [Abstract][Full Text] [Related]
13. EMP1, EMP 2, and EMP3 as novel therapeutic targets in human cancer.
Wang YW; Cheng HL; Ding YR; Chou LH; Chow NH
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):199-211. PubMed ID: 28408326
[TBL] [Abstract][Full Text] [Related]
14. TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme.
Kuijlen JM; Mooij JJ; Platteel I; Hoving EW; van der Graaf WT; Span MM; Hollema H; den Dunnen WF
J Neurooncol; 2006 Jun; 78(2):161-71. PubMed ID: 16544055
[TBL] [Abstract][Full Text] [Related]
15. Biobanking: An Important Resource for Precision Medicine in Glioblastoma.
Tan SY; Sandanaraj E; Tang C; Ang BT
Adv Exp Med Biol; 2016; 951():47-56. PubMed ID: 27837553
[TBL] [Abstract][Full Text] [Related]
16. Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcome.
Wadehra M; Natarajan S; Seligson DB; Williams CJ; Hummer AJ; Hedvat C; Braun J; Soslow RA
Cancer; 2006 Jul; 107(1):90-8. PubMed ID: 16736513
[TBL] [Abstract][Full Text] [Related]
17. TREM2 function in glioblastoma immune microenvironment: Can we distinguish reality from illusion?
Ghosh S; Rothlin CV
Neuro Oncol; 2024 May; 26(5):840-842. PubMed ID: 38290471
[No Abstract] [Full Text] [Related]
18. Therapeutic strategies for inhibiting invasion in glioblastoma.
Drappatz J; Norden AD; Wen PY
Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303
[TBL] [Abstract][Full Text] [Related]
19. Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma.
Jun F; Hong J; Liu Q; Guo Y; Liao Y; Huang J; Wen S; Shen L
Oncotarget; 2017 Feb; 8(9):14343-14358. PubMed ID: 27527869
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis reveals drug accessible cell surface N-glycoproteins of primary and established glioblastoma cell lines.
Bock T; Moest H; Omasits U; Dolski S; Lundberg E; Frei A; Hofmann A; Bausch-Fluck D; Jacobs A; Krayenbuehl N; Uhlen M; Aebersold R; Frei K; Wollscheid B
J Proteome Res; 2012 Oct; 11(10):4885-93. PubMed ID: 22909291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
